猪肺炎支原体气溶胶免疫减毒活疫苗的表型特征与保护效力
研究开发了定制超声雾化器用于猪肺炎支原体(Mhp)气溶胶疫苗,测定雾化后空气动力学直径与活菌含量,并对仔猪进行气溶胶免疫及攻毒保护试验。雾化后疫苗实际滴度较理论值下降0.6 CCU50,气溶胶颗粒可到达下呼吸道并诱导局部黏膜免疫,攻毒后肺病变指数显著下降。
要点
- 雾化结束及10分钟后气溶胶MMAD分别为2.98±0.02 μm和2.76±0.02 μm。
- 雾化后疫苗实际滴度较理论值下降0.6 CCU50。
- 气溶胶免疫可诱导仔猪局部黏膜免疫并显著降低攻毒后肺病变指数。
核心结论
- 研究成功开发了一种有效的抗Mhp感染气溶胶疫苗,并首次对Mhp活疫苗气溶胶化抗感染效果进行了有效评估。
研究设计与样本
- 研究开发定制超声雾化器,测定Mhp气溶胶疫苗的空气动力学直径、活性和含量,并对仔猪进行气溶胶免疫及动物攻毒保护试验以评估免疫效果。
主要发现
- 雾化结束时气溶胶的质量中位空气动力学直径(MMAD)为2.98±0.02 μm,几何标准差(GSD)为1.51±0.02;雾化后10分钟MMAD为2.76±0.02 μm,GSD为1.51±0.01,几乎无变化。
- 雾化后疫苗实际滴度(以50%变色单位CCU50计)较理论值下降0.6。
- 疫苗原液和10倍稀释疫苗溶液产生的气溶胶中Mhp比例分别为76.52%和58.82%,单个气溶胶中Mhp平均数量分别为3.06和1.51。
- 气溶胶疫苗抗原颗粒可到达下呼吸道,在仔猪中诱导局部黏膜免疫,疫苗定植呼吸道并显著降低气溶胶免疫后的肺病变指数。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
With the improvement of large-scale breeding in pig farms, conventional head-by-head immunization has disadvantages with low efficiency and high cost. Considering that most pathogens leading to pulmonary diseases circulate from the respiratory mucosa, immunization through the respiratory tract route has been a highly attractive vaccine delivery strategy. In this study, to develop an effective Mycoplasma hyopneumoniae (Mhp) aerosol vaccine, a customized ultrasonic atomizer was developed. The aerodynamic diameter, activity, and content of the Mhp aerosol vaccine were measured. In addition, piglets were immunized with the Mhp aerosol vaccine, and the immunity of the animal challenge protection test was evaluated. At the end of nebulization, the mass median aerodynamic diameters (MMAD) and geometric standard deviation (GSD) of the aerosol were 2.98 ± 0.02 μm and 1.51 ± 0.02, respectively. Moreover, 10 min after nebulization, the MMAD and GSD of the aerosol were 2.76 ± 0.02 μm and 1.51 ± 0.01, respectively, which were hardly changed. Compared with theoretical value, the actual titer of aerosol vaccines presented in 50% color changing unit (CCU50) after nebulization decreased 0.6. The shape, size, and uniformity of collected aerosols are relatively stable. The proportion of Mhp in aerosol produced by vaccine stock solution and 10 times diluted vaccine solution was 76.52% and 58.82%, respectively, and the average number of Mhp in a single aerosol was 3.06 and 1.51, respectively. In addition, the aerosol vaccine antigen particles could be transported to the lower respiratory tract, a local mucosal immune response was induced in piglets. The vaccine colonized the respiratory tract and significantly decline the lung lesion index after aerosol vaccination. In conclusion, an effective aerosol vaccine against Mhp infection was developed. And this is the first effective assessment for Mhp live vaccine with aerosolization against infection in piglets.
引用
- Hao F, Bai Y, Xie X, et al. Phenotypic characteristics and protective efficacy of an attenuated Mycoplasma hyopneumoniae vaccine by aerosol administration. Vaccine. 2022. PMID: 36109278. doi:10.1016/j.vaccine.2022.08.072
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。